Anti-synthetase syndrome-associated interstitial lung disease possibly caused by atezolizumab in a patient with lung adenocarcinoma: a case report.
Ippei MiyamotoTetsuo ShimizuRyo KusahanaMasayuki NomotoDaishi FujiwaraTsukasa NishizawaKentaro HayashiYoshiko NakagawaYasuhiro GonPublished in: BMC pulmonary medicine (2023)
The examination of anti-ARS antibodies pior to the administration of ICIs may be useful in predicting the development of ASS-ILD.